Methodology
Methodology hub
How we define concepts, grade evidence, normalize pricing, rank, verify pharmacies, and stay consistent.
This methodology explains how Microdose GLP One defines dose concepts, grades evidence, captures and normalizes provider pricing, decides ranking eligibility, verifies pharmacies, and keeps public data consistent. Every published number ships with a status, a capture date, and a source.
Definition method
Every page names the exact dose concept from an eleven-item firewall and never treats a starter dose, reduced maintenance dose, provider 'microdose', or compounded oral product as interchangeable.
Evidence grading
Claims are graded from randomized trial down to no-direct-evidence, following the evidence policy. Provider-reported and verified figures are labeled separately.
Pricing normalization
We store advertised, first-month, renewal, effective monthly, and total-obligation figures separately, fold mandatory fees into effective cost, and use one canonical record for HTML, prose, JSON, and CSV so they can't disagree.
Ranking eligibility
A program is excluded from rankings when pricing is approximate, stale, promotional in a recurring category, conflicting, or missing fees, shipping, quantity, or dose coverage. Rankings publish only when a like-for-like eligible sample is certified.
Pharmacy verification
We confirm legal identity, license, 503A/503B status, and recall/discipline records — see the pharmacy hub. Registration is never treated as approval.
Freshness & consistency
Pricing targets a 7–14 day recheck, regulatory monitoring is ongoing, and stale figures drop out of conclusions. Public JSON/CSV match the visible values at each snapshot.
Not medical advice. This page is consumer education, not medical advice, and does not recommend a dose, product, or provider. Compounded medications are not FDA approved. Talk with a licensed clinician about your situation.